ArteraAI The Centers for Medicare & Medicaid Services (CMS) have established a payment rate for the ArteraAI prostate cancer test, a multimodal artificial intelligence (MMAI) biomarker

Deep Learning algorithm for Gleason scoring A Nature.com Digital Medicine paper

nanoknife.com/ IRE (Irreversible Electroporation)  effectively destroys targeted tissue giving you precise treatment margins resulting in confident treatment coverage 

Nabla Copilot automatically generates clinical notes, reducing stress and improving patient care.

ncbi.nlm.nih.gov/pmc/articles/PMC10445392/ Use of AI in the detection of primary prostate cancer in multiparametric MRI and clinical outcome

Prostate.Carcinoma. Enhancing MRI with AI ​

Pubmed.ncbi.nlm.nih.gov/37406864/ needs further studies, to fully understand the capabilities and limitations of AI-generated Prostate Cancer information.

UCLA grant  UCLA receives $3 Million Grant to develop AI for Prostate Cancer detection

​

​

​